Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Purdue Pharma LP | 174 |
| 2 | AbbVie Inc | 118 |
| 3 | Bausch Health Companies Inc | 102 |
| 4 | Johnson and Johnson | 90 |
| 5 | Pfizer Inc | 57 |
| 6 | Merck and Co Inc | 56 |
| 7 | Sanofi SA | 56 |
| 8 | Vertex Pharmaceuticals Inc | 51 |
| 9 | Japan Tobacco Inc | 45 |
| 10 | Leland Stanford Junior University | 43 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 1,744 |
| 2 | A61P | Therapeutic activity (drug indications) | 1,731 |
| 3 | C07K | Peptides | 950 |
| 4 | C07D | Heterocyclic compounds | 611 |
| 5 | C12N | Microorganisms, enzymes | 393 |
| 6 | G01N | Investigating / analysing materials | 390 |
| 7 | C07C | Acyclic and carbocyclic compounds | 139 |
| 8 | C12Q | Measuring/testing involving enzymes | 118 |
| 9 | C12Y | Enzyme nomenclature (EC numbers) | 118 |
| 10 | Y02A | Climate change adaptation | 98 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| USE OF MELANIN CONCENTRATING HORMONE AND MET-ENKEPHALIN AS THERAPEUTIC AGENTS | 2009 | Relief Therapeutics Holding SA | 4 |
| USE OF MET-ENKEPHALIN AS A THERAPEUTIC AGENT | 2009 | Relief Therapeutics Holding SA | 3 |
| Aerosol contg. met-enkephalin | 2006 | 2 | |
| USE OF MET-ENKEPHALIN AS A THERAPEUTIC AGENT | 2009 | Relief Therapeutics Holding SA | 0 |
| USE OF MELANIN CONCENTRATING HORMONE AND MET-ENKEPHALIN AS THERAPEUTIC AGENTS | 2009 | Relief Therapeutics Holding SA | 0 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Santosh Pasha | Institute of Genomics and Integrative Biology | 8 |
| 2 | Luisa Giari | University of Ferrara | 8 |
| 3 | Christoph Stein | Charité - Universitätsmedizin Berlin | 7 |
| 4 | Heike L. Rittner | Franklin University | 6 |
| 5 | Bahram Sayyaf Dezfuli | University of Ferrara | 6 |
| 6 | Shaaban A. Mousa | Franklin University | 5 |
| 7 | Halina Machelska | Freie Universität Berlin | 4 |
| 8 | Susan Ingram | Washington State University Vancouver | 4 |
| 9 | David C. Yeomans | Stanford University | 4 |
| 10 | Bernd A. Berg | Florida State University | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| The potential influence of maternal stress hormones on development and mental health of the offspring | 2004 | 708 | Stress Responses and Cortisol |
| Regular Exercise Reverses Sensory Hypersensitivity in a Rat Neuropathic Pain Model | 2011 | 318 | Neurotransmitter Receptor Influence on Behavior |
| Structure of Met‐enkephalin in explicit aqueous solution using replica exchange molecular dynamics | 2001 | 283 | Protein Structure and Dynamics |
| A Kinetic Model of Trp-Cage Folding from Multiple Biased Molecular Dynamics Simulations | 2009 | 275 | Protein Structure and Dynamics |
| Nucleus Accumbens μ-Opioid Receptors Mediate Social Reward | 2011 | 270 | Neurotransmitter Receptor Influence on Behavior |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Met-enkephalin?
Which organizations hold the most patents for Met-enkephalin?
How much research activity has been documented for Met-enkephalin?
What therapeutic applications of Met-enkephalin have been patented?
What research topics are most commonly associated with Met-enkephalin in peer-reviewed literature?